Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult ParticipantsCompleted
NCT05852340Phase 1Updated Oct 16, 2024
Sponsor: Pfizer
Healthy Volunteers · Adult · Pharmacokinetics
Belgium
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiSRecruiting
NCT03728478Phase 3Updated Oct 15, 2024
Sponsor: Istituto Giannina Gaslini
Oligoarthritis, Juvenile · Polyarthritis, Juvenile, Rheumatoid Factor Negative
Italy
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCompleted
NCT05375929Phase 3Updated Oct 15, 2024
Sponsor: Pfizer
Atopic Dermatitis
India
Study of GBT021601 in Participants With Renal ImpairmentTerminated
NCT05878704Phase 1Updated Oct 15, 2024
Sponsor: Pfizer
Renal Impairment
United States
STUDY OF PF-07321332 IN HEALTHY PARTICIPANTSCompleted
NCT04756531Phase 1Updated Oct 15, 2024
Sponsor: Pfizer
Healthy Participants
United States, Belgium
Enhancing Therapy Adherence Among Metastatic Breast Cancer PatientsCompleted
NCT06161181NAUpdated Oct 15, 2024
Sponsor: European Institute of Oncology
Metastatic Breast Cancer
Italy
A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.Completed
NCT05554237Phase 1Updated Oct 10, 2024
Sponsor: Pfizer
Healthy
Belgium
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 YearsCompleted
NCT04895982Phase 2Updated Oct 9, 2024
Sponsor: BioNTech SE
SARS-CoV-2 Infection, COVID19
United States, Brazil, Germany, Mexico
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not HospitalizedCompleted
NCT05799495Phase 2Updated Oct 9, 2024
Sponsor: Pfizer
SARS-CoV-2 Infection
United States
A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World SettingCompleted
NCT05487703N/AUpdated Oct 8, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
Morocco
Xeljanz Special Investigation for Long-term Use in UC PatientsCompleted
NCT03643211N/AUpdated Oct 8, 2024
Sponsor: Pfizer
Ulcerative Colitis
Japan
A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding WomenCompleted
NCT06453356Phase 1Updated Oct 8, 2024
Sponsor: Pfizer
Healthy
United States
A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy AdultsCompleted
NCT06466473Phase 1Updated Oct 8, 2024
Sponsor: Pfizer
Healthy
United States
A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of AgeCompleted
NCT05650333Phase 1Updated Oct 8, 2024
Sponsor: Pfizer
Alopecia Areata
United States
A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.Completed
NCT05339334Phase 1Updated Oct 8, 2024
Sponsor: Pfizer
Healthy Participants
China
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/RitonavirCompleted
NCT05567952Phase 2Updated Oct 8, 2024
Sponsor: Pfizer
COVID-19
United States, Canada, Greece, Italy, Taiwan
A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in Healthy AdultsCompleted
NCT06393517Phase 1Updated Oct 8, 2024
Sponsor: Pfizer
Healthy Participants
United States
Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor AloneCompleted
NCT05012644N/AUpdated Oct 8, 2024
Sponsor: Pfizer
Metastatic Breast Cancer
United States
RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.Completed
NCT04460898N/AUpdated Oct 4, 2024
Sponsor: Pfizer
Breast Cancer
United States
A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.Completed
NCT05822440Phase 1Updated Oct 4, 2024
Sponsor: Pfizer
Healthy
United States
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.Completed
NCT05375955Phase 2Updated Oct 2, 2024
Sponsor: Pfizer
Atopic Dermatitis · Plaque Psoriasis
United States, Canada, Japan, United Kingdom
A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy AdultsCompleted
NCT06347861Phase 1Updated Oct 1, 2024
Sponsor: Pfizer
Healthy
United States
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLCTerminated
NCT04325698Phase 3Updated Oct 1, 2024
Sponsor: Pfizer
Advanced Non-squamous NSCLC
China
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes MellitusCompleted
NCT04889157Phase 1Updated Oct 1, 2024
Sponsor: Pfizer
Diabetes Mellitus, Type 2
China
IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid ArthritisCompleted
NCT03981900N/AUpdated Oct 1, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
France

Previous page Next page